Abstract
A total of 276 cervical swabs (241 from first visits and 35 from follow-up visits) from 241 women were tested forChlamydia trachomatis by polymerase chain reaction (PCR) and enzyme immunoassay (EIA). Sixty-one smears (53 from first visits and 8 from follow-up visits) from 53 women were stained by direct fluorescent antibody (DFA). Twenty-one (8.7%) women had positive swabs in at least two different tests. All follow-up swabs (collected between 3 days and 3 weeks after the first clinical visit) were positive in at least one test when the woman had been positive at the first visit and no antibiotic treatment had been initiated. Including swabs from follow-up visits and DFA results, the respective sensitivities and specificities of the assays were as follows: PCR, 75.9% and 100%; EIA, 69% and 98.4%. The seven swabs that were false negative by PCR (tested initially after thawing from-20°C) were mailed nonrefrigerated to the assay manufacturer, where they tested true positive. These data point to labile inhibitors of the PCR, predominantly cervical mucus.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Piot P, Van den Hoek AR, Van Damme L, Laga M: Epidemiology and control of genital chlamydial infection. In: Chlamydial infections. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Societa Editrice Esculapio, Bologna, 1994, p. 7–16.
Brunham RC, Maclean IW, Binns B, Peeling RW:Chlamydia trachomatis: its role in tubal infertility. Journal of Infectious Diseases 1985, 152: 1275–1282.
Barnes RC: Laboratory diagnosis of human chlamydial infection. Clinical Microbiology Reviews 1989, 2: 119–136.
Lefebvre J, Laperriere H, Rousseau H, Masse R: Comparison of three techniques for detection ofChlamydia trachomatis in endocervical specimens from asymptomatic women. Journal of Clinical Microbiology 1988, 4: 726–731.
Thomas BJ, MacLeod EJ, Taylor-Robinson D: Evaluation of a commercial polymerase chain reaction assay forChlamydia trachomatis and suggestions for improving sensitivity. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 719–723.
Loeffelholz MJ, Lewinski CA, Silver SR, Purohit AP, Herman SA, Bounagurio DA, Dragon EA: Detection ofChlamydia trachomatis in endocervical specimens by polymerase chain reaction. Journal of Clinical Microbiology 1992, 30: 2847–2851.
Bass CA, Jungkind DL, Silverman NS, Bondi JM: Clinical evaluation of a new polymerase chain reaction assay for detection ofChlamydia trachomatis in endocervical specimens. Journal of Clinical Microbiology 1993, 31: 2648–2653.
Bauwens JE, Clark AM, Stamm WE: Diagnosis ofChlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. Journal of Clinical Microbiology 1993, 31: 3023–3027.
Embil JA, Thiébaux J, Manuel FR, Pereira LH, MacDonald SW: Sequential cervical specimens and the isolation ofChlamydia trachomatis: factors affecting detection. Sexually Transmitted Diseases 1983, 10: 62–66.
Munday PE, Carder JM, Hanna NF, Taylor-Robinson D: Is one swab enough to detect chlamydial infection of the cervix? British Journal of Venereal Diseases 1984, 60: 384–386.
Dunlop EMC, Goh BT, Darougar S, Woodland R: Tripleculture tests for diagnosis of chlamydial infection of the female genital tract. Sexually Transmitted Diseases 1985, 12: 68–71.
Phillips RS, Hanff PA, Kauffman RS, Aronson, MD: Use of a direct fluorescent antibody test for detectingChlamydia trachomatis cervical infection in women seeking routine gynecologic care. Journal of Infectious Diseases 1987, 156: 575–581.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clad, A., Naudascher, L., Flecken, U. et al. Evidence of labile inhibitors in the detection ofChlamydia trachomatis in cervical specimens by polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis. 15, 744–747 (1996). https://doi.org/10.1007/BF01691963
Issue Date:
DOI: https://doi.org/10.1007/BF01691963